Christopher Liddle
Impact in
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
- Hepatology top 0.5%
- Hepatitis C virus research
Papers in
- Pharmacology 41
- Pharmacogenetics and Drug Metabolism 38
- Hepatology 37
- Hepatitis C virus research 24
- Liver physiology and pathology 17
- Co-authors
- Michael Downes (48 shared papers)Ronald Evans (45 shared papers)G C Farrell (36 shared papers)Annette R. Atkins (24 shared papers)Bryan J. Goodwin (12 shared papers)Ruth T. Yu (35 shared papers)Jacob George (22 shared papers)Maryam Ahmadian (7 shared papers)
- Journals
- Hepatology (17 papers)Proceedings of the National Academy of Sciences (12 papers)Nature Communications (7 papers)Journal of Gastroenterology and Hepatology (7 papers)Nature (6 papers)
- Partner nations
- AustraliaUnited StatesGermany
In The Last Decade
Christopher Liddle
187 papers receiving 19.4k citations
Christopher Liddle's Hit Papers
Peers
Comparison fields: 5 of 142
- Pharmacology 2.8k
- Hepatology 1.6k
- Endocrine and Autonomic Systems 1k
- Oncology 3.3k
- Epidemiology 4.2k
Countries citing papers authored by Christopher Liddle
This map shows the geographic impact of Christopher Liddle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Liddle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Liddle more than expected).
Fields of papers citing papers by Christopher Liddle
This network shows the impact of papers produced by Christopher Liddle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Liddle. The network helps show where Christopher Liddle may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher Liddle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PPARγ signaling and metabolism: the good, the bad and the future Hit paper breakdown → | 2013 | 1696 |
| 2 | Vitamin D Receptor-Mediated Stromal Reprogramming Suppresses Pancreatitis and Enhances Pancreatic Cancer Therapy Hit paper breakdown → | 2014 | 975 |
| 3 | NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome Hit paper breakdown → | 2002 | 972 |
| 4 | Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β Hit paper breakdown → | 2012 | 900 |
| 5 | Orphan Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Share Xenobiotic and Steroid Ligands Hit paper breakdown → | 2000 | 716 |
| 6 | Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance Hit paper breakdown → | 2015 | 642 |
| 7 | 1999 | 581 | |
| 8 | A Vitamin D Receptor/SMAD Genomic Circuit Gates Hepatic Fibrotic Response Hit paper breakdown → | 2013 | 537 |
| 9 | Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis Hit paper breakdown → | 1998 | 527 |
| 10 | An inhibitor of the protein kinases TBK1 and IKK-ɛ improves obesity-related metabolic dysfunctions in mice Hit paper breakdown → | 2013 | 386 |
| 11 | 2019 | 385 | |
| 12 | 1996 | 349 | |
| 13 | 2008 | 335 | |
| 14 | In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. | 2001 | 315 |
| 15 | 2002 | 307 | |
| 16 | Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation Hit paper breakdown → | 2019 | 287 |
| 17 | 2015 | 284 | |
| 18 | Immune-evasive human islet-like organoids ameliorate diabetes Hit paper breakdown → | 2020 | 280 |
| 19 | 2017 | 251 | |
| 20 | 2002 | 223 |
About Christopher Liddle
Christopher Liddle is a scholar working on Pharmacology, Hepatology, Oncology, Epidemiology and Molecular Biology, having authored 189 papers that have together received 19.9k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (38 papers), Hepatitis C virus research (24 papers), Drug Transport and Resistance Mechanisms (20 papers), Liver Disease Diagnosis and Treatment (18 papers), Liver physiology and pathology (17 papers), Adipose Tissue and Metabolism (10 papers), Hepatitis B Virus Studies (7 papers) and Pancreatic and Hepatic Oncology Research (6 papers). The work is most often cited by research in Pharmacology (2.8k citations), Hepatology (1.6k citations), Endocrine and Autonomic Systems (1k citations), Oncology (3.3k citations) and Epidemiology (4.2k citations). Christopher Liddle has collaborated with scholars based in Australia, United States and Germany. Frequent co-authors include Michael Downes, Ronald Evans, G C Farrell, Annette R. Atkins, Bryan J. Goodwin, Ruth T. Yu, Jacob George, Maryam Ahmadian, Nasun Hah and Jae Myoung Suh. Their work appears in journals such as Hepatology, Proceedings of the National Academy of Sciences, Nature Communications, Journal of Gastroenterology and Hepatology and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.